Copyright
©The Author(s) 2022.
World J Hepatol. Apr 27, 2022; 14(4): 766-777
Published online Apr 27, 2022. doi: 10.4254/wjh.v14.i4.766
Published online Apr 27, 2022. doi: 10.4254/wjh.v14.i4.766
Markers of decompensated cirrhosis | N (%) | Adjusted odds | Lower limit | Upper limit | P value |
Hypoalbuminemia | 460 (4) | 1.38 | 1.04 | 1.82 | < 0.05 |
Hepatic encephalopathy | 1855 (16) | 3.06 | 2.41 | 3.9 | < 0.05 |
Portal vein thrombosis | 310 (3) | 1.13 | 0.72 | 1.77 | 0.6 |
Variceal upper GI bleed | 825 (7) | 1.81 | 1.03 | 3.19 | < 0.05 |
Ascites | 2155 (18) | 1.91 | 1.62 | 2.27 | < 0.05 |
Coagulopathy | 1290 (11) | 2.18 | 1.86 | 2.56 | < 0.05 |
SBP | 295 (2) | 2.38 | 0.69 | 8.32 | 0.17 |
Hepatorenal syndrome | 945 (8) | 1.69 | 1.22 | 2.34 | < 0.05 |
- Citation: Dar SH, Rahim M, Hosseini DK, Sarfraz K. Impact of liver cirrhosis on ST-elevation myocardial infarction related shock and interventional management, a nationwide analysis. World J Hepatol 2022; 14(4): 766-777
- URL: https://www.wjgnet.com/1948-5182/full/v14/i4/766.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i4.766